CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- Open-market buys, last 90 days
- $60,455
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$60,455. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-25 | LEDERMAN SETH Chief Executive Officer | Purchase | +100,000 | $0.25 | $25K | 112,177 |
| 2022-02-15 | SULLIVAN GREGORY M Chief Medical Officer | Grant or award · Stock Option | +1,250,000 | 1,250,000 | ||
| 2022-02-15 | SULLIVAN GREGORY M Chief Medical Officer | Grant or award · Stock Option | +1,250,000 | 1,250,000 | ||
| 2022-02-15 | SULLIVAN GREGORY M Chief Medical Officer | Grant or award · Stock Option | +1,250,000 | 1,250,000 | ||
| 2022-02-15 | SULLIVAN GREGORY M Chief Medical Officer | Grant or award · Stock Option | +1,250,000 | 1,250,000 | ||
| 2022-02-15 | SAENGER BRADLEY Chief Financial Officer | Grant or award · Stock Option | +900,000 | 900,000 | ||
| 2022-02-15 | SAENGER BRADLEY Chief Financial Officer | Grant or award · Stock Option | +900,000 | 900,000 | ||
| 2022-02-15 | SAENGER BRADLEY Chief Financial Officer | Grant or award · Stock Option | +900,000 | 900,000 | ||
| 2022-02-15 | SAENGER BRADLEY Chief Financial Officer | Grant or award · Stock Option | +900,000 | 900,000 | ||
| 2022-02-15 | MORRIS JESSICA EDGAR Chief Operating Officer | Grant or award · Stock Option | +1,100,000 | 1,100,000 | ||
| 2022-02-15 | MORRIS JESSICA EDGAR Chief Operating Officer | Grant or award · Stock Option | +1,100,000 | 1,100,000 | ||
| 2022-02-15 | MORRIS JESSICA EDGAR Chief Operating Officer | Grant or award · Stock Option | +1,100,000 | 1,100,000 | ||
| 2022-02-15 | MORRIS JESSICA EDGAR Chief Operating Officer | Grant or award · Stock Option | +1,100,000 | 1,100,000 | ||
| 2022-02-15 | LEDERMAN SETH Chief Executive Officer | Grant or award · Stock Option | +5,000,000 | 5,000,000 | ||
| 2022-02-15 | LEDERMAN SETH Chief Executive Officer | Grant or award · Stock Option | +5,000,000 | 5,000,000 | ||
| 2022-02-15 | LEDERMAN SETH Chief Executive Officer | Grant or award · Stock Option | +5,000,000 | 5,000,000 | ||
| 2022-02-15 | LEDERMAN SETH Chief Executive Officer | Grant or award · Stock Option | +5,000,000 | 5,000,000 | ||
| 2021-09-28 | LEDERMAN SETH Chief Executive Officer | Purchase | +12,000 | $0.61 | $7K | 12,177 |
| 2021-07-16 | Taylor Carolyn E. Director | Grant or award · Stock Option | +237,437 | 237,437 | ||
| 2021-05-25 | Goodman Daniel Wintner Director | Purchase | +5,000 | $1.12 | $6K | 5,001 |
Page 6 of 25 · 482 trades